Stress-Protective Effect of Thymic Peptides
Gespeichert in:
Verfasser / Beitragende:
[A. Novoseletskaya, N. Kiseleva, I. Zimina, O. Belova, A. Inozemtsev, V. Arion, V. Sergienko]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 158/6(2015-04-01), 753-755
Format:
Artikel (online)
Online Zugang:
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605537542 | ||
| 003 | CHVBK | ||
| 005 | 20210128100858.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150401xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2854-4 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2854-4 | ||
| 245 | 0 | 0 | |a Stress-Protective Effect of Thymic Peptides |h [Elektronische Daten] |c [A. Novoseletskaya, N. Kiseleva, I. Zimina, O. Belova, A. Inozemtsev, V. Arion, V. Sergienko] |
| 520 | 3 | |a Experiments on Wistar rats showed that thymic peptides produce a stress-protective effect that manifested in prevention of functional impairment of conditioned active avoidance response and a decrease in generalized motor activity typical of higher nervous activity failure. We concluded that thymic peptides significantly modulate integrative functions of the brain and produce a stress-protective effect. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a tactivin |2 nationallicence | |
| 690 | 7 | |a avoidance response |2 nationallicence | |
| 690 | 7 | |a functional impairment |2 nationallicence | |
| 690 | 7 | |a stress |2 nationallicence | |
| 700 | 1 | |a Novoseletskaya |D A. |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia |4 aut | |
| 700 | 1 | |a Kiseleva |D N. |u Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | |
| 700 | 1 | |a Zimina |D I. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | |
| 700 | 1 | |a Belova |D O. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | |
| 700 | 1 | |a Inozemtsev |D A. |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia |4 aut | |
| 700 | 1 | |a Arion |D V. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | |
| 700 | 1 | |a Sergienko |D V. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/6(2015-04-01), 753-755 |x 0007-4888 |q 158:6<753 |1 2015 |2 158 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2854-4 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2854-4 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Novoseletskaya |D A. |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kiseleva |D N. |u Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Zimina |D I. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Belova |D O. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Inozemtsev |D A. |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Arion |D V. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Sergienko |D V. |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/6(2015-04-01), 753-755 |x 0007-4888 |q 158:6<753 |1 2015 |2 158 |o 10517 | ||